Skip to content

Link Between Rheumatoid Arthritis & Lung Disease

Search Clinical Trials

Trial Objectives


The purpose of this study is to determine the development and progression of rheumatoid arthritis -associated lung disease (RA-LD) over time and to learn about the body’s generation of auto-antibodies in the blood. Researchers are trying to understand who develops rheumatoid arthritis (RA) and which RA patients go on to develop RA-LD, as well as how to prevent and treat the disease

Who Can Participate


Individuals with rheumatoid arthritis (RA), interstitial lung disease (ILD) or lung fibrosis may be eligible to participate.

Age: 18+ Gender Any

Estimated Time Commitment


6 in-person visits, performed every year over 4 years

Payment & Reimbursement


Payment Not Provided

Travel Reimbursement Not Available

Trial Contact


For more information, contact:

Faduma Ahmed
303.398.1285

Request More Information

Trial Location


National Jewish Main Campus, Denver, CO

Trial Sponsors


Pfizer

Principal Investigators

Joshua J. Solomon

Joshua J. Solomon, MD

Co-Investigators

Michael P. Mohning

Michael P. Mohning, MD

Request more Information

By completing this form, you agree to learn more about this study and see if you qualify.

I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health required